New hospital program aims to keep COPD patients out of trouble after Flare-Ups

NCT ID NCT06646419

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This study tests whether a structured care program (called a transition bundle) helps people with COPD recover better after a serious flare-up. The program includes guided steps and regular check-ins. About 1,368 patients across 36 hospitals will take part. The goal is to see if this approach reduces the chance of their condition getting worse again.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Post-exacerbation transition bundle (a set of care steps and audits)
What this could lead to: If successful, this program could become a standard way to help COPD patients avoid serious worsening after a flare-up.
What could go wrong: This is a cluster trial testing a care process, not a new drug. Results may vary by hospital and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD

Contacts and locations

Locations

Research Site

Anyang, China
Research Site

Baise City, China
Research Site

Beijing, China
Research Site

Bijie, China
Research Site

Changsha, China
Research Site

Chenzhou, China
Research Site

Chifeng, China
Research Site

Chuzhou, China
Research Site

Deyang, China
Research Site

Fuyang, China
Research Site

Hangzhou, China
Research Site

Hefei, China
Research Site

Jieyang, China
Research Site

Jining, China
Research Site

Jiujiang, China
Research Site

Kaiyuan, China
Research Site

Langfang, China
Research Site

Langzhong, China
Research Site

Leping, China
Research Site

Nanchang, China
Research Site

Nanchong, China
Research Site

Neijiang, China
Research Site

Qiannan, China
Research Site

Qujing, China
Research Site

Sanmenxia, China
Research Site

Shaoyang, China
Research Site

Suzhou, China
Research Site

Tengzhou, China
Research Site

Tieling, China
Research Site

Wenzhou, China
Research Site

Xiangtan, China
Research Site

Xiaogan, China
Research Site

Xinyang, China
Research Site

Yancheng, China
Research Site

Yichang, China
Research Site

Yuling, China
Research Site

Zaoyang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.